Promoting clinical breast evaluations in a lower middle–income country Setting: An approach toward achieving a sustainable breast health program by Buribekova, Roziya et al.
eCommons@AKU
Medical College Documents Medical College, Pakistan
September 2018
Promoting clinical breast evaluations in a lower
middle–income country Setting: An approach
toward achieving a sustainable breast health
program
Roziya Buribekova
Aga Khan Health Services, Dushanbe, Tajikistan
Irina Shukurbekova
Aga Khan Health Services, Dushanbe, Tajikistan
Surayo Ilnazarova
Aga Khan Health Services, Dushanbe, Tajikistan
Nekruz Jamshevov
Aga Khan Health Services, Dushanbe, Tajikistan
Guldarbogh Sadonshoeva
Aga Khan Health Services, Dushanbe, Tajikistan
See next page for additional authors
Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_mc
Part of the Medical Genetics Commons
Recommended Citation
Buribekova, R., Shukurbekova, I., Ilnazarova, S., Jamshevov, N., Sadonshoeva, G., Sayani, S., Aminmuhammad, A., Amersi, F., Asaria,
S., Saleh, M., Talib, Z. (2018). Promoting clinical breast evaluations in a lower middle–income country Setting: An approach toward
achieving a sustainable breast health program. Journal of global oncology, 4, 1-8.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_mc/94
Authors
Roziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, Guldarbogh Sadonshoeva,
Saleem Sayani, Aliya Aminmuhammad, Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib
This report is available at eCommons@AKU: https://ecommons.aku.edu/pakistan_fhs_mc_mc/94
1  jgo.org JGO – Journal of Global Oncology
© 2018 by American Society of Clinical Oncology Licensed under the Creative Commons Attribution 4.0 License
Promoting Clinical Breast Evaluations 
in a Lower Middle–Income Country 
Setting: An Approach Toward Achieving a 
Sustainable Breast Health Program
INTRODUCTION
Breast cancer remains the number one cause of 
female mortality in lower middle–income countries 
(LMICs).1 Whereas a lack of adequate diagnostic 
and therapeutic resources has been identified as 
a major hurdle in the optimal delivery of breast 
cancer care, delayed diagnosis continues to be 
an area of significant concern. Lack of awareness 
about breast cancer in the population, lack of 
health care professionals who are trained in clin-
ical breast examination (CBE), and inadequate 
diagnostic and treatment resources contribute to 
a delay in medical intervention and treatment.2
The rates of early detection and improved sur-
vival observed in at upper middle–income coun-
tries (UMICs)3 cannot be readily replicated in 
LMICs. In contrast, training of health care profes-
sionals in CBE and the incorporation of CBE into 
the routine clinical evaluation of adult female 
patients represents an opportunity for the early 
identification and clinical downstaging of breast 
cancer at the time of presentation.4
We embarked on a multidisciplinary approach to 
introduce context-relevant comprehensive breast 
health in an LMIC setting. In Gorno Badakhshan, 
we observed a close-knit community with a 
well-organized infrastructure to support health 
care. A public-private partnership between the 
Aga Khan Health Services, Tajikistan (AKHSTj), 
and the Department of Health of Gorno Badak-
shan Autonomous Oblast (GBAO) has resulted 
in a functional, three-tiered delivery of health 
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of all screened women.
Conclusion A dual-pronged approach of community awareness and CBE training of health care 
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detection and treatment of breast cancer across the region.
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care in this isolated mountainous region in the 
South East of Tajikistan. Primary tier 1 basic care 
at the village level is provided by trained fam-
ily medicine nurses (FMNs) who provide health 
education and low-level maternity/postpartum 
and basic screening services, secondary tier 2 
care at the district clinic is provided by trained 
family medicine doctors (FMDs), and tertiary tier 
3 specialized care is provided at the Oblast cap-
ital in Khorugh, with subspecialty referrals to the 
federal capital in Dushanbe (Fig 1).
Between 2014 and 2017, volunteer clinicians 
from the Aga Khan Health Board (AKHB-USA) 
collaborated with AKHSTj to introduce breast can-
cer awareness in GBAO, with a focus on develop-
ing a sustainable program of CBE and helping to 
improve diagnostic and therapeutic services ded-
icated to breast cancer. The inaugural AKHB-USA 
team consisted of a multidisciplinary team of cli-
nicians, surgeons, radiologists, and pathologists 
who established a framework for breast cancer 
awareness and multidisciplinary management.5
Here, we present the outcome of these efforts to 
promote CBE proficiency and the dissemination 
of breast cancer awareness and evaluation in the 
remote districts of this mountainous region. The 
host team included AKHSTj staff and FMDs and 
FMNs from each district.
METHODS
The overall aim of our current effort was to 
increase breast cancer awareness throughout 
GBAO and for CBE to became a formal exam 
for all women older than age 35 years who visit 
family medicine clinics in the districts. After the 
initial rollout of the CBE screening and training 
campaign,5 we developed a strategy to promote 
breast health beyond the principal city of Khorog. 
To accomplish this, we introduced the concept 
of CBE master trainers (CBE-MTs), who received 
additional CBE training and mentoring and 
demonstrated proficiency in the CBE technique 
and teaching.5 To enable the introduction of CBE 
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Fig 1. Breast cancer 
program initiative in the 
Department of Health of 
the Autonomous Oblast of 
Gorno Badakshan. AKDN, 
Aga Khan Development 
Network.
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into the districts, the CBE-MT subsequently con-
ducted trainings with FMNs from each of the 
districts. In turn, these FMNs, independently 
or in conjunction with the district FMDs, con-
ducted CBE screening drives in each of their 
respective districts. All CBEs were conducted in 
the various family medicine clinics as part of the 
breast cancer awareness program. All women 
who presented for CBE provided informed con-
sent.5 Women with an abnormal CBE as identi-
fied by the FMN and/or FMD were subsequently 
re-examined by a visiting CBE-MT. Women with 
confirmed abnormal CBE were referred to the 
Khorog Regional Diagnostic Unit for diagnostic 
evaluation according to our previously described 
CBE algorithm5 and referred for additional diag-
nostic evaluation and treatment as appropriate. 
Data from each of the districts were collected 
and verified by AKHSTj staff.
RESULTS
During the inaugural rollout of the program in 2014, 
we provided hands-on CBE training to 28 FMDs 
and seven FMNs. Four hundred forty-one women 
from the community underwent CBE, and 74 
women (17%) had an abnormal exam and under-
went diagnostic evaluation. Of these, six patients 
(1.4% of total screened) were diagnosed with 
locally advanced breast cancer and received treat-
ment as part of this campaign. The work reporting 
this result has been previously published.5
In 2015, after the initial training, 80 female staff 
members from the local Aga Khan Development 
Network units were offered CBE by the CBE-MT. 
Fifty women consented and underwent CBE. 
Seven women (14%) had abnormal CBE, but no 
breast pathology was detected on follow-up diag-
nostic evaluation in this young patient population, 
all of whom were younger than age 40 years.
During subsequent visits in 2015 and 2016, 
34 FMDs and 18 FMNs received didactic and 
hands-on CBE training from AKHB-USA cli-
nicians. Some of the participating FMDs and 
FMNs were part of the original group in 2014 
and thus underwent retraining. Overall, a total 
of 42 FMDs—representing 85% of the FMDs in 
GBAO—underwent CBE training. During these 
visits, six CBE-MTs were selected and given 
additional mentored training.
In 2016, these six CBE-MTs, in turn, inde-
pendently provided CBE training to 147 FMNs 
from the districts. Thus, in aggregate, a total of 
166 FMNs—representing 55% of the FMNs in 
GBAO—received CBE training, with some partic-
ipating in more than one training session. These 
trained FMNs went on to conduct breast screen-
ing campaigns in their respective districts.
In the process, over a 30-month period, a total 
of 3,556 women in GBAO have undergone CBE. 
Of these, 696 women (20% of all screened) were 
found to have an abnormal CBE, and breast can-
cer was identified in 18 women—2.6% of abnor-
mal CBEs or 0.5% of all screened women.
Table 1 lists the CBE capacity and the commu-
nity screening accomplished as an outcome 
of this ongoing collaborative partnership since 
inception in 2014.
Whereas the six patients in the original 2014 
CBE campaign all had locally advanced breast 
cancer (clinical stage III or greater), nine of 10 
patients who were diagnosed during the 2016 
to 2017 screening campaign had locoregional 
disease (clinical stage II).
Of note, 1,101 women were independently 
screened by FMNs in the district between Jan-
uary and February 2017, identifying 96 women 
(9.5%) with an initial abnormal CBE, who were 
then re-examined by CBE-MTs. Subsequent dia-
gnostic evaluation revealed two women with 
localized breast cancer (0.2% of all screened 
women).
DISCUSSION
With a rise in noncommunicable disease in 
LMICs6 and a focus on women’s health, breast 
cancer deserves heightened attention in all 
LMICs, given its prevalence and impact on the 
quality of life of the individual and family unit. 
The common occurrence of late presentation 
and advanced stage in LMICs compared with 
UMICs7 contributes to morbidity, a substantial 
loss of productive life for patients and productive 
capacity within the community, and, ultimately, 
to increased breast cancer mortality.6,7
Data that support the benefits of early detection 
stems from UMICs,7-10 where resources and 
capabilities seem to be limitless. Thus, only one 
in seven women (15%) in UMICs presents with 
locally advanced or metastatic breast cancer.11 
This is in contrast to LMICs, where nearly two of 
three women have locally advanced or metastatic 
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disease at the time of presentation.7 In the con-
text of LMICs, where diagnostic and treatment 
resources are limited, and with no public health 
policy that advocates early detection, downstag-
ing of breast cancer at the time of initial detection 
offers a pragmatic approach to impact morbidity, 
quality of life, and survival.7,12-15 A critical prereq-
uisite for downstaging at presentation is breast 
cancer awareness on the part of women in the 
community and health care providers, the train-
ing of health care providers in CBE technique, 
and the promotion of breast health as part of 
women’s health in the clinical setting.16-18
Our efforts were directed at bringing awareness of 
breast cancer and training the local clinicians— 
FMDs and FMNs—in the early detection of 
breast abnormality in the context of promoting 
CBE and breast health throughout this moun-
tainous region, where access to health care 
faces socioeconomic hurdles as well as those of 
climate and terrain. In this context, the AKHSTj 
has established a remarkable model infrastruc-
ture with which to provide basic health resources 
in each of the mountainous districts through 
their system of tier 1 district clinics supported by 
FMNs and visiting FMDs as well as by a network 
of community lay volunteers.
We began with training FMDs and FMNs in CBE 
and conducting initial CBE drives in the Oblast 
capital in Khorog.5 The success of this inaugural 
program was evident by the participation of more 
than 400 women, the training of 35 health care 
providers, and the identification of six patients 
with breast cancer, all of whom received appro-
priate treatment, established a supportive, trust-
ing environment and the motivation to continue 
the collaborative effort. In total, 42 FMDs (85% 
of all FMDs in GBAO) and 166 FMNs (55% 
of FMNs in GBAO) have since received CBE 
training as part of this project. Of importance, 
a majority of the FMNs (147 of 166) received 
their CBE training from the six CBE-MTs and 
have gone on to provide the bulk of the CBE 
screening in the remote district locations. Thus, 
the biggest incremental increase in CBE train-
ing and women screened occurred as a result of 
the efforts of the trained and experienced local 
CBE-MTs. Consequently, nearly 1,100 women 
underwent CBE in the districts over a 2-month 
period in 2017 compared with 2,400 as part of 
the original screening drives in Khorugh during 
the previous 2-year period.
Our data demonstrate a consistent improvement 
in CBE proficiency by FMDs and FMNs as they 
became more experienced at performing CBEs 
(Table 1). Thus, 14% to 27% of women who 
were screened between 2014 and 2016 had 
what were characterized as abnormal exams 
compared with 9% during the most recent CBE 
campaign in 2017. The screening campaigns 
often generated great community interest and 
participation, and many younger women in child-
bearing age present for CBE. Thus, the fluctu-
ating frequency of abnormal CBE (27% to 9%) 
may reflect the initial lack of experience and 
proficiency on the part of clinicians, as well as 
the palpation of normal, age-related, benign 
findings in young women who present for 
screening.19
The identification of approximately 1% breast 
cancer (0.2% to 1.4% of all screened women; 
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Table 1. Outcome of CBE Training and Screening Campaign
Outcome
2014 AKHB- 
USA AKHSTj 
CBE Campaign
2015 AKHB- 
USA AKHSTj  
CBE Campaign
2016 AKHB- 
USA AKHSTj 
CBE Campaign
2016 AKHSTj CBE 
 Campaign
2017 AKHSTj CBE 
Campaign, January 
and February Total
FMDs trained, No. 28 6 28* NA NA 42†
FMNs trained, No. 7 6 12* 147 NA 166†
Patients screened, No. 441 50 108 1,856 1,101 3,556
Abnormal CBE, No. (%) 74 (17) 7 (14) 26 (24) 493 (27) 96 (9) 696 (20)
Breast cancer, No. (% of 
abnormal CBE)
6 (8) 0 2 (8) 8 (2) 2 (2) 18 (2.6)
Breast cancer, No. (% of 
all screened)
6 (1.4) 0 2 (1) 8 (0.4) 2 (0.2) 18 (0.5)
Abbreviations: AKHB-USA, Aga Khan Health Board; AKHSTj, Aga Khan Health Services, Tajikistan; CBE, clinical breast examination; FMD, family medicine doctor; 
FMN, family medicine nurse; NA, not applicable.
*Number reflects retraining of some FMDs and FMNs.
†Aggregate numbers are lower than total because some FMDs and FMNs attended more than one training session.
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Table 1) during our community CBE screening 
campaign is comparable to that which has been 
described by others,20-24 including findings from 
a large community-based, clustered randomized 
control study using trained health care workers 
in India.20 In general, one in 10 women who 
present at community screening campaigns 
will have an abnormal CBE, and approximately 
1% of the screened population will be diag-
nosed with breast cancer. These rates may 
often fluctuate depending on the age of the 
screened population and the proficiency of the 
examiner.
Over a 3-year period, we trained (or retrained) a 
majority (85%) of the FMDs and nearly one half 
of FMNs in GBAO. The identification of a cadre 
of CBE-MTs from within the FMDs served to pro-
mote the process of ongoing retraining and adju-
dication of abnormal exams and reflects a major 
success of the program, as it assures the sustain-
ability of our strategy and an internal self-renewal 
process for the training of new clinicians as well 
as the ongoing training/monitoring of trained pro-
fessionals. The engagement of FMNs from the 
district assures the promotion of breast health 
throughout this remote region and underscores 
the value of the AKHSTj network. Over time, we 
hope to expand the pool of CBE-MTs and train 
one FMN master trainer for each district site.
Our program served to establish a network of 
health care professionals who are equipped to 
perform CBEs, provided a mechanism for ongo-
ing training and the adjudication of abnormal 
CBEs, and contributed to the earlier identification 
of women with abnormal breast masses, thereby 
contributing to the earlier identification of breast 
cancer. In the absence of surgical staging data 
for all women who were diagnosed with breast 
cancer as part of our campaign, and given the 
relatively recent implementation of this program, 
we are unable to determine the impact of our 
program on the downstaging of breast cancer at 
time of identification.20,25 However, we observed 
that fewer women with clinical locally advanced 
tumor masses (clinical stage III or greater) were 
identified during our subsequent campaigns in 
2016 and 2017 compared with our initial cam-
paign in 2014. Thus, all six women with breast 
cancer who were identified in our original cam-
paign in 2014 had clinical locally advanced 
stage III or greater disease,5 whereas only one 
of 10 women who were identified during the 
subsequent campaigns had clinical advanced 
stage disease. This was an elderly woman who 
had known about her breast mass for more than 
1 year, but had declined intervention, yet was 
encouraged by her family to participate in the 
screening campaign in 2016. The patient went 
on to undergo a palliative mastectomy for her 
T4 breast tumor. The awareness on the part of 
the family and the trusting relationship that 
was established between the CBE team and 
the community played an important role in 
encouraging such patients to undergo screening. 
As part of this project, we identified the need for 
an experienced psychosocial counselor to provide 
support to the patient and family in response to 
the diagnosis of cancer in a cultural environment 
in which cancer remains stigmatized.
A key accomplishment of our joint AKHB– 
AKHSTj program was the adoption of CBE as a 
routine part of a woman’s exam by the FMD at the 
Khorog Family Medicine Clinic. Whereas most 
women attended this clinic for routine ailments, 
the practice of including CBE provided both 
experience for the FMD and an opportunity to 
promote breast health in the female population. 
Key to sustaining our efforts will be this hands-on 
practice and an ongoing campaign to incorporate 
CBE in the general female examination, a prac-
tice change that will require endorsement by the 
health authorities. In addition, we are working 
with AKHSTj and the health department to advo-
cate for the documentation of CBE findings using 
a simple form designed as part of our campaign. 
This form would be completed by the examiner 
and placed in the patient’s chart for future refer-
ence (Fig 2). This is especially relevant for the 
observation of women with nonspecific abnor-
mal CBE findings living in remote districts, where 
mammography and/or ultrasound resources are 
not readily available and travel to the diagnostic 
center is not feasible or affordable.
Most women in the distant villages may not 
be able to afford or may lack the resources to 
travel to the regional center for diagnostic imag-
ing, especially during the harsh winter that lasts 
nearly 5 months and where there is no access 
for motorized transportation. Even during the 
normal season, travel through the mountainous 
terrain is often on foot or by animal cart. Docu-
mentation of the findings on the CBE form (Fig 
2) would help to monitor patients with iden-
tified CBE abnormality, allow follow-up even 
when health care providers change, and allow 
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the provider to alert the patient and family if a 
follow-up CBE reveals objectively documented 
signs of progression of the abnormal finding.
In 2014, during our initial campaign in Khorog, 
we were able to collect demographic and clinical 
information from all patients.5 Subsequent CBE 
campaigns in the district were conducted with-
out the collection of such data. The introduction 
of CBE documentation and nominal data collec-
tion is an important goal, but will require input 
from the health authorities.
Our project, conducted over 3 years, demonstrates 
not only the feasibility, but the sustainability, of this 
effort through a dedicated public-private partner-
ship and a commitment to improving breast cancer 
awareness within the community and breast health 
within the medical systems. The success of this 
program, to date, has been the result of a focused 
approach on community awareness; identification 
and mentored training of CBE-MTs, and sustain-
able training/retraining of FMDs and FMNs; a uni-
form, algorithm-based approach for the diagnostic 
evaluation of abnormal findings; and initial efforts 
at incorporating CBE in routine women’s clinical 
evaluation. Furthermore, the involvement of FMNs 
at the forefront of the CBE campaign has ensured 
the dissemination of the program throughout the 
Oblast, with FMDs and CBE-MTs often serving as 
the second tier for evaluation. This strategy has 
allowed CBE services to be provided to women 
who live away from the major center and contribute 
to creating an Oblast-wide awareness of the impor-
tance of breast health.
Ongoing monitoring and re-evaluation of the 
program will be critical to ensuring its long-
term success, which can then be linked to the 
enhancement of diagnostic and treatment ser-
vices as more patients with cancer are discov-
ered and the demand for advanced breast health 
services increases. Such efforts will also need to 
be accompanied by the introduction of clinical 
documentation and data collection as part of this 
effort. Although our program shows evidence of 
traction within the local health care community, 
the institutionalization of CBE within the health 
care system, financial coverage of diagnostic 
studies and treatment that are often unaffordable 
to many patients, and the negative stigma linked 
to the diagnosis of breast cancer in the commu-
nity will need to be addressed strategically if we 
are to succeed in promoting overall breast health 
in the region. Ultimately, it will take health policy 
directives to provide the institutional imperative 
to support these lifesaving initiatives. Our study 
shows that strategically designed, goal-oriented 
public-private partnership focused on training of 
local resources can be transformative in LMICs 
in tackling the increasing burden of noncommu-
nicable disease, specifically breast cancer.
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